In vitro tumor microenvironment sensing: one step closer to personalized medicine
Cancer is one of the deadliest diseases to date. Due to the variation in types of cancer, treatment remains a challenge. This variation even exists within the same cancer type between patients and even within tumors [1]. The interpatient variability at the genetic level is a major driving factor behind the failure of treatment response. As the metabolic pathways are extraordinarily complex, the probability of a similar set of mutations in each patient is very unlikely, therefore, there is a huge demand for personalized treatment, where each patient could be treated based on their condition. One step in this direction...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
